Parenteral cytotoxic drug wastage at a tertiary hospital in Kuala Lumpur: How much and why?

Zen Yang AngKit Yee CheahNadiah B AbdullahSafawati B SamsuriSiao Hui LeeAndrew Wh YemMalathi Ap Sriraman

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Wastage associated to non-preventable reasons such as adverse drug reactions and preventable causes like refusal of patients can be further reduced by using newer healthcare innovations and establishment of written institutional protocols or standard operating procedures as references for in-charge healthcare personnel when cytotoxic drug-related issues occur. Adoption of cost-saving strategies that have been proven by studies could further improve current cost containment strategies.

Keyphrases

adverse drug
healthcare
electronic health record
end stage renal disease
drug induced
emergency department
newly diagnosed
patient reported outcomes
patient reported
case control